Company Overview

Update
Founded:
2005
Headquarters:
Waltham, MA
Funding:
$43.3M
Categories:
Biotechnology
Description:
Syndax Pharmaceuticals is focused on developing an HDAC inhibitor for solid tumors and hematological tumors.

Detailed Description

Update

Syndax Pharmaceuticals specializes is a clinical-stage pharmaceutical company focused on an HDAC inhibitor for solid tumors and hematological tumors

Current Team (3)

Update

Past Team (2)

Update

Funding Rounds (4) - $43.3M

Update

Board Members and Advisors (1)

Update

Investors (6)

Update
  • 6e0c2eff9a1ba00055ff746b9a935256

    Forward Ventures

    Venture capital Firm
  • 5c88874bab246f05ba9ce93503ddf1d4

    RusnanoMedInvest

    RusnanoMedInvest invests in pharmaceuticals and medical developmental businesses based in the...
  • 4034eeea2f11df7bf15ebdf27c6d8cf7

    MPM Capital

    Healthcare Venture Capital
  • 0a3acad2d1a668f5769bee7f82e0eb3a

    Domain Associates

    Founded in 1985, Domain Associates, L.L.C. is a venture capital firm with an exclusive focus on...
  • 81dd9f355a80474e8fd113c5e40e8612

    Avalon Ventures

    Avalon Ventures is an early stage venture capital fund focused on information technology and life...
  • E6ea97e0b800a210997784d58a6ffb5c

    Pappas Ventures

    At Pappas Ventures, their sole focus is investing in the life sciences – biotechnology,...

Offices/Locations (1)

Update
  • Headquarters

    460 Totten Pond Road

    Suite 650

    Waltham, MA 02451

    USA

Images (1)

Update
  • B924e61b1697c3e8826a00a999330866